Global Pneumococcal Vaccines Market Predicted to Grow with a CAGR of 3.3% During the Forecast Period, 2019-2025 - ResearchAndMarkets.com

DUBLIN--()--The "Pneumococcal Vaccines Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025" report has been added to ResearchAndMarkets.com's offering.

The report predicts the global pneumococcal vaccines market to grow with a CAGR of 3.3% over the forecast period from 2019-2025.
The report on the global pneumococcal vaccines market provides qualitative and quantitative analysis for the period from 2017 to 2025. The study on pneumococcal vaccines market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on pneumococcal vaccines market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global pneumococcal vaccines market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global pneumococcal vaccines market over the period of 2017 to 2025. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

  • Increasing number of people suffering from pneumococcal disease
  • Rising availability of pneumococcal vaccination
  • Huge investments and partnerships by the pharmaceutical companies

2) Restraints

  • High costs required in the manufacturing of pneumococcal vaccines

3) Opportunities

  • Research and development
What does this report deliver?

1. Comprehensive analysis of the global as well as regional markets of the pneumococcal vaccines market.

2. Complete coverage of all the segments in the pneumococcal vaccines market to analyze the trends, developments in the global market and forecast of market size up to 2025.

3. Comprehensive analysis of the companies operating in the global pneumococcal vaccines market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Key Topics Covered:

1. Preface

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

2. Executive Summary

2.1. Pneumococcal Vaccines Market Highlights

2.2. Pneumococcal Vaccines Market Projection

2.3. Pneumococcal Vaccines Market Regional Highlights

3. Global Pneumococcal Vaccines Market Overview

3.1. Introduction

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. Porter's Five Forces Analysis

3.4. Growth Matrix Analysis

3.4.1. Growth Matrix Analysis by Product Type

3.4.2. Growth Matrix Analysis by Distribution Channel

3.4.3. Growth Matrix Analysis by Region

3.5. Value Chain Analysis of Pneumococcal Vaccines Market

4. Pneumococcal Vaccines Market Macro Indicator Analysis

5. Global Pneumococcal Vaccines Market by Product Type

5.1. Pneumococcal Conjugate Vaccine

5.2. Pneumococcal Polysaccharide Vaccine

6. Global Pneumococcal Vaccines Market by Distribution Channel

6.1. Clinics

6.2. Hospitals

6.3. Non-governmental Organizations

6.4. Government Authorities

7. Global Pneumococcal Vaccines Market by Region 2019-2025

7.1. North America

7.1.1. North America Pneumococcal Vaccines Market by Product Type

7.1.2. North America Pneumococcal Vaccines Market by Distribution Channel

7.1.3. North America Pneumococcal Vaccines Market by Country

7.2. Europe

7.3. Asia-Pacific

7.4. RoW

8. Company Profiles and Competitive Landscape

8.1. Competitive Landscape in the Global Pneumococcal Vaccines Market

8.2. Companies Profiled

8.2.1. Bayer AG

8.2.2. GlaxoSmithKline plc

8.2.3. Pfizer Inc.

8.2.4. Nuron Biotech Inc.

8.2.5. CSL Ltd.

8.2.6. Biomed Pvt. Ltd.

8.2.7. Serum Institute of India Pvt. Ltd.

8.2.8. Sanofi Pasteur Inc.

8.2.9. JN-International Medical Corporation

8.2.10. Merck & Co., Inc.

For more information about this report visit https://www.researchandmarkets.com/r/rkie4e

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900